Literature DB >> 2341198

Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood of man.

G Zwadlo-Klarwasser1, S Bent, H D Haubeck, C Sorg, W Schmutzler.   

Abstract

The effect of intravenous administration of the glucocorticoid prednylidene on the macrophage subtype RM 3/1 in the peripheral blood of man was studied. Injection of 60 mg steroid resulted in an increase in the proportion of RM 3/1 positive monocytes 12 h after application from the basic level to about 80%. After 24 h the number of RM 3/1 positive cells decreased but remained elevated over the basis rate for a period of at least 15 days. Similar results were obtained after administration of 30 or 6 mg prednylidene even if the peak value occurred with a delay of 12 h after 6 mg. A dose- and time-dependent induction of the RM 3/1 positive subtype could also be demonstrated in vitro by the addition of prednylidene or dexamethasone to cultured purified human monocytes/macrophages. Deoxycortone or indomethacin had no effects. These results suggest that glucocorticoids exert their influence on cells of the mononuclear phagocytic lineage by inducing a distinct monocyte/macrophage subpopulation which seems to be associated with anti-inflammatory functions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341198     DOI: 10.1159/000235111

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  19 in total

1.  Inflammatory reactions in primary osteoarthritis of the hip and total hip prosthesis loosening.

Authors:  B Greitemann; B Mues; J Polster; T Pauly; C Sorg
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

2.  Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

Authors:  G Fingerle-Rowson; M Angstwurm; R Andreesen; H W Ziegler-Heitbrock
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

3.  Biochemical characterization of a glucocorticoid-induced membrane protein (RM3/1) in human monocytes and its application as model system for ranking glucocorticoid potency.

Authors:  P Högger; U Erpenstein; P Rohdewald; C Sorg
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

4.  Macrophage reactions in septic arthritis.

Authors:  K M Peters; K Koberg; T Rosendahl; B Klosterhalfen; A Straub; G Zwadlo-Klarwasser
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

5.  Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes.

Authors:  W Hamann; A Flöter; W Schmutzler; G Zwadlo-Klarwasser
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

6.  Immunohistochemical expression of MPO, CD163 and VEGF in inflammatory cells in acute respiratory distress syndrome: a case report.

Authors:  Milan Maretta; Stefan Toth; Zuzana Jonecova; Peter Kruzliak; Peter Kubatka; Stanislava Pingorova; Jarmila Vesela
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

7.  Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro.

Authors:  S Goerdt; R Bhardwaj; C Sorg
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 8.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

9.  Macrophages in melanocytic naevi.

Authors:  E B Bröcker; C Reckenfeld; H Hamm; D J Ruiter; C Sorg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  Pattern of macrophage subpopulations in post-traumatic bone infections after combined operative/antibiotic treatment.

Authors:  K M Peters; T Rosendahl; K W Zilkens; G Zwadlo-Klarwasser
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.